The Oncology Institute, Inc.

NasdaqCM:TOI Stock Report

Market Cap: US$354.4m

Oncology Institute Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:TOI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Sep 25SellUS$20,703,000M33 Growth, LLCCompany6,700,000US$3.09
19 Aug 25SellUS$82,097Bradford HivelyIndividual20,221US$4.06
05 Jun 25SellUS$2,287,500M33 Growth, LLCCompany750,000US$3.05
03 Jun 25SellUS$311,519Bradford HivelyIndividual108,532US$2.87
20 May 25SellUS$5,425,800M33 Growth, LLCCompany2,000,000US$2.71
26 Mar 25BuyUS$9,434Jeremy CastleIndividual9,056US$1.04
26 Mar 25BuyUS$37,735Karen Marie JohnsonIndividual36,224US$1.04
26 Mar 25BuyUS$9,434Robert CarterIndividual9,056US$1.04
26 Mar 25BuyUS$9,434Yale PodnosIndividual9,056US$1.04
26 Mar 25BuyUS$23,584Daniel VirnichIndividual22,640US$1.04
26 Mar 25BuyUS$94,338Mark PacalaIndividual90,562US$1.04
26 Mar 25BuyUS$1,415,095RAB Ventures, IncCompany1,358,448US$1.04
26 Mar 25BuyUS$47,168Bradford HivelyIndividual45,280US$1.04
02 Dec 24BuyUS$50,000Bradford HivelyIndividual300,000US$0.17

Insider Trading Volume

Insider Buying: TOI insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TOI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,418,6027.93%
VC/PE Firms8,523,2819.12%
Institutions33,278,55035.6%
General Public44,284,33447.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.9%.

Top Shareholders

Top 25 shareholders own 47.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.12%
M33 Growth, LLC
8,523,281US$32.3m-44%no data
4.58%
The Vanguard Group, Inc.
4,280,887US$16.2m145%no data
4.4%
Ravi Sarin
4,109,771US$15.6m0%no data
3.89%
TIFF Advisory Services, LLC
3,634,465US$13.8m22%3.17%
3.59%
Deerfield Management Company, L.P.
3,360,052US$12.7m0%0.2%
3.54%
BlackRock, Inc.
3,306,904US$12.5m1,160%no data
2.69%
Balyasny Asset Management L.P.
2,518,337US$9.5m17.3%0.02%
2.62%
Josh Arnold Investment Consultant, LLC
2,446,550US$9.3m23%7.26%
1.58%
Marshall Wace LLP
1,476,946US$5.6m0%0.01%
1.54%
RAB Ventures, Inc
1,438,788US$5.5m5.91%100.0%
1.37%
Geode Capital Management, LLC
1,279,443US$4.8m232%no data
1.28%
Richard Barasch
1,197,093US$4.5m0%no data
1.2%
Wexford Capital LP
1,118,679US$4.2m0%0.56%
0.77%
Centerbook Partners LP
715,899US$2.7m0%0.14%
0.69%
State Street Global Advisors, Inc.
646,257US$2.4m538%no data
0.5%
Daniel Virnich
467,061US$1.8m6.68%no data
0.49%
Bradford Hively
459,872US$1.7m4.42%no data
0.49%
Renaissance Technologies LLC
457,500US$1.7m84.8%no data
0.45%
UBS Asset Management AG
420,373US$1.6m4,070%no data
0.44%
Northern Trust Global Investments
411,357US$1.6m434%no data
0.43%
Millennium Management LLC
405,009US$1.5m0%no data
0.43%
Massar Capital Management, LP
400,000US$1.5m300%1.05%
0.42%
FourWorld Capital Management LLC
391,650US$1.5m52.4%1.12%
0.37%
Freegulliver, L.L.C.
343,800US$1.3m-36.8%0.59%
0.3%
Two Sigma Investments, LP
278,165US$1.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/17 13:03
End of Day Share Price 2025/10/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Oncology Institute, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan ZhiB. Riley Securities, Inc.
David LarsenBTIG
Alexander DraperGuggenheim Securities, LLC